These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3044374)

  • 21. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
    Bandilla K; Missler B; Klein-Reesink B
    Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical assessment of a group of children with juvenile rheumatoid arthritis receiving long-term treatment with oral gold salt].
    Mignone F; Sardella ML; Clara L; Barrett S; Basano R; Barbero I
    Minerva Pediatr; 1992 Dec; 44(12):617-22. PubMed ID: 1363792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
    Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
    Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmarketing experience with auranofin in the Federal Republic of Germany.
    Schattenkirchner M; Missler B; Mulz D
    Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.
    Carette S; Calin A; McCafferty JP; Wallin BA
    Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
    Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
    J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auranofin-associated colitis and eosinophilia.
    Michet CJ; Rakela J; Luthra HS
    Mayo Clin Proc; 1987 Feb; 62(2):142-4. PubMed ID: 3807438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pyritinol and auranofin in the treatment of rheumatoid arthritis. The European Multicentre Study Group.
    Lemmel EM
    Br J Rheumatol; 1993 May; 32(5):375-82. PubMed ID: 8495257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.
    Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Irby R; Wolfe F
    Arthritis Rheum; 1990 Mar; 33(3):330-8. PubMed ID: 2180405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
    Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
    J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical response to auranofin in patients with psoriatic arthritis.
    Salvarani C; Zizzi F; Macchioni P; Mantovani W; Rossi F; Baricchi R; Bellelli A; Capozzoli N; Frizziero L; Portioli I
    Clin Rheumatol; 1989 Mar; 8(1):54-7. PubMed ID: 2743720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.